

Author: Hatoum Hind T Crawford E David Nielsen Sandy Kildegaard Lin Swu-Jane Marshall Dennis C
Publisher: Informa Healthcare
ISSN: 1473-7167
Source: Expert Review of Pharmacoeconomics and Outcomes Research, Vol.13, Iss.2, 2013-04, pp. : 261-270
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Hatoum Hind T Crawford E David Nielsen Sandy Kildegaard Lin Swu-Jane Marshall Dennis C
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. :






Hormonal therapy in advanced prostate cancer examined
Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. :


Degarelix: a guide to its use in advanced prostate cancer
Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. :